These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35065101)
1. Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: A randomized controlled trial. Yoo JH; Kim G; Lee HJ; Sim KH; Jin SM; Kim JH Diabetes Res Clin Pract; 2022 Feb; 184():109209. PubMed ID: 35065101 [TBL] [Abstract][Full Text] [Related]
2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ; JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683 [TBL] [Abstract][Full Text] [Related]
3. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566 [TBL] [Abstract][Full Text] [Related]
4. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial. Lind N; Christensen MB; Hansen DL; Nørgaard K Diabetes Care; 2024 May; 47(5):881-889. PubMed ID: 38489032 [TBL] [Abstract][Full Text] [Related]
5. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM; JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682 [TBL] [Abstract][Full Text] [Related]
6. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol. Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR; BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714 [TBL] [Abstract][Full Text] [Related]
7. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Miller KM; Kanapka LG; Rickels MR; Ahmann AJ; Aleppo G; Ang L; Bhargava A; Bode BW; Carlson A; Chaytor NS; Gannon G; Goland R; Hirsch IB; Kiblinger L; Kruger D; Kudva YC; Levy CJ; McGill JB; O'Malley G; Peters AL; Philipson LH; Philis-Tsimikas A; Pop-Busui R; Salam M; Shah VN; Thompson MJ; Vendrame F; Verdejo A; Weinstock RS; Young L; Pratley R Diabetes Technol Ther; 2022 Jun; 24(6):424-434. PubMed ID: 35294272 [No Abstract] [Full Text] [Related]
8. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Reddy M; Jugnee N; Anantharaja S; Oliver N Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562 [TBL] [Abstract][Full Text] [Related]
9. FGM-based remote intervention for adults with type 1 diabetes: The FRIEND randomized clinical trial. Lee J; Lee MH; Park J; Kim KS; Kim SK; Cho YW; Han HW; Song YS Front Endocrinol (Lausanne); 2022; 13():1054697. PubMed ID: 36506077 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group Diabetes Care; 2021 Feb; 44(2):464-472. PubMed ID: 33334807 [TBL] [Abstract][Full Text] [Related]
11. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E; Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468 [TBL] [Abstract][Full Text] [Related]
12. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D; JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453 [TBL] [Abstract][Full Text] [Related]
13. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial. Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331 [TBL] [Abstract][Full Text] [Related]
14. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL. Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500 [TBL] [Abstract][Full Text] [Related]
15. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial. Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range. Puhr S; Calhoun P; Welsh JB; Walker TC Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082 [TBL] [Abstract][Full Text] [Related]
17. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials. Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743 [TBL] [Abstract][Full Text] [Related]
18. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548 [TBL] [Abstract][Full Text] [Related]
19. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. McAuley SA; Lee MH; Paldus B; Vogrin S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Trawley S; Ward GM; Jenkins AJ; Jones TW; O'Neal DN; Diabetes Care; 2020 Dec; 43(12):3024-3033. PubMed ID: 33055139 [TBL] [Abstract][Full Text] [Related]
20. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial. Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]